Contineum Therapeutics, Inc.
CTNMCIK 0001855175 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
56,342 bought / 60,512 sold
net −4,170 sh · −$872.9K
- buys
- 6
- sells
- 6
- insiders active
- 3
Filing tape
Filed Wed, Jul 8, 2026
- −0 sh · $37.5K
Stengone Carmine N. — CEO and President · Director
- Exercised2,500Class A Common Stock@ $1.01→ 19,717 held
- Sold2,500Class A Common Stock@ $16.00→ 17,217 held
- Exercised2,500Stock Option (right to buy)→ 279,430 held
Filed Thu, Jul 2, 2026
- −4,170 sh · $561.2K
Lorrain Daniel S. — Chief Scientific Officer
- Exercised28,826Class A Common Stock@ $1.01→ 168,198 held
- Sold28,826Class A Common Stock@ $16.04→ 139,372 held
- Exercised4,183Class A Common Stock@ $1.01→ 143,555 held
- Sold5,852Class A Common Stock@ $15.67→ 137,703 held
- Sold2,501Class A Common Stock@ $16.24→ 135,202 held
- Exercised28,826Stock Option (right to buy)→ 38,480 held
- Exercised4,183Stock Option (right to buy)→ 34,297 held
Filed Wed, Jul 1, 2026
- −0 sh · $124.8K
Watkins Tim — CMO & Head of Development
- Exercised10,833Class A Common Stock@ $4.50→ 19,794 held
- Sold10,833Class A Common Stock@ $16.02→ 8,961 held
- Exercised10,833Stock Option (right to buy)→ 238,334 held
- −0 sh · $149.4K
Stengone Carmine N. — CEO and President · Director
- Exercised7,500Class A Common Stock@ $1.01→ 24,717 held
- Exercised2,500Class A Common Stock@ $1.26→ 27,217 held
- Sold10,000Class A Common Stock@ $16.01→ 17,217 held
- Exercised7,500Stock Option (right to buy)→ 281,930 held
- Exercised2,500Stock Option (right to buy)→ 118,417 held
Insiders on this tape
- Stengone Carmine N.CEO and President · Director
- Lorrain Daniel S.Chief Scientific Officer
- Watkins TimCMO & Head of Development
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.